BI 409306

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for BI 409306, covering 2017-10-19 to 2024-09-03. Get the full timeline:

Most recent: Clinical Trial Update: BI 409306 Cardiac Safety Trial in Healthy Volunteers [Phase 1]